Cargando…
The Value of Combined Use of Survivin mRNA and Matrix Metalloproteinase 2 and 9 for Bladder Cancer Detection in Voided Urine
Objective: In a trial to improve the diagnostic efficacy of conventional urine cytology we determine survivin RNA and matrix metalloproteinase 2 and 9 in urine of bladder cancer cases. Method: Voided urine specimens were collected from patients with histologically confirmed bladder urothelial carcin...
Autores principales: | Eissa, Sanaa, Badr, Soheir, Abd Elhamid, Shadia, Helmy, Azza Salah, Nour, Mohamed, Esmat, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810229/ https://www.ncbi.nlm.nih.gov/pubmed/22960341 http://dx.doi.org/10.3233/DMA-2012-0923 |
Ejemplares similares
-
Utility of urine cytology in evaluating hematuria with sonographically suspected bladder lesion in patients older than 50 years
por: Mady, Hussam Eldin Helmy, et al.
Publicado: (2014) -
Detection of bladder cancer using voided urine sample and by targeting genomic VPAC receptors
por: Nerli, Rajendra B., et al.
Publicado: (2021) -
Evaluation of a New Survivin ELISA and UBC(®)
Rapid for the Detection of Bladder Cancer in Urine
por: Gleichenhagen, Jan, et al.
Publicado: (2018) -
Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand
por: Jia, Xing-You, et al.
Publicado: (2012) -
Nuclear Matrix Protein 22 in Voided Urine Cytology Efficacy in Risk Stratification for Carcinoma of Bladder
por: Sankhwar, Monica, et al.
Publicado: (2013)